ImmunoGen Inc (NASDAQ:IMGN)
| 5.93 Delayed Data As of Jan 18 |  -0.56 / -8.63%Today’s Change | 4.72 Today|||52-Week Range 10.88 | -20.08% Year-to-Date |
Latest IMGN News | Press Releases
| Why Sutro Biopharma Stock Is Losing Ground Today Jan 06 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 6.49 |
| Today’s open | 6.44 |
| Day’s range | 5.92 - 6.38 |
| Volume | 161,821 |
| Average volume (3 months) | 3,238,905 |
| Market cap | $1.4B |
Data as of 4:01pm ET, 01/18/2022
Growth & Valuation
| Earnings growth (last year) | +64.12% |
| Earnings growth (this year) | -172.80% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +60.81% |
| P/E ratio | NM |
| Price/Sales | 8.59 |
| Price/Book | 14.11 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ATRAAtara Biotherapeutic... | -1.15 | -7.16% |
| ALECAlector Inc | -1.47 | -8.40% |
| BCYCBicycle Therapeutics... | -1.62 | -3.34% |
| MYOVMyovant Sciences Ltd | -0.62 | -4.04% |
Data as of 4:01pm ET, 01/18/2022
Financials
| Next reporting date | February 11, 2022 |
| EPS forecast (this quarter) | -$0.18 |
| Annual revenue (last year) | $132.3M |
| Annual profit (last year) | -$44.4M |
| Net profit margin | -33.54% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Waltham, Massachusetts |
Forecasts
